Seeking Alpha

Tonix Pharma expects results on fibromyalgia test during H2, shares +5.7%

  • Tonix Pharmaceuticals (TNXP +5.7%) says it expects to report results from Phase IIb testing of its TNX-102 SL drug candidate in patients with fibromyalgia during H2 2014.
  • TNXP says it began enrollment in the BESTFIT trial last September which was expected to monitor ~120 patients split equally between groups receiving either TNX-102 SL or placebo, measuring changes in pain intensity.
  • TNXP also says it expects to begin a trial of TNX-102 SL as a potential treatment for post-traumatic stress disorder and tension-type headache during Q3 and Q4, respectively.
Comments (2)
  • chiefsfan37
    , contributor
    Comments (2) | Send Message
     
    Has anyone here looked into topical pain relief to fight fibro pain? It provides prescription strength pain relief without any pills or side effects. A family member of mine gets topical pain gels through a pharmacy in the midwest, A&R Pharmacy in Liberty, MO, and all he does is apply the gel whenever he's in pain. He has had significant results since going this route and I highly recommend it for anyone struggling with pain and/or pills. I hope this helps!
    4 Feb, 06:24 PM Reply Like
  • Patent News
    , contributor
    Comments (1312) | Send Message
     
    they are speaking at roth conference tomorrow, buy before!

     

    CEO is a good speaker.
    10 Mar, 11:48 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|